[1] |
HAO Xian, HUANG Jianjun, YANG Wenxiu, LIU Jinting, ZHANG Junhong, LUO Yubei, LI Qing, WANG Dahong, GAO Yuwei, TAN Fuyun, BO Li, ZHENG Yu, WANG Rong, FENG Jianglong, LI Jing, ZHAO Chunhua, DOU Xiaowei.
Establishment of primary breast cancer cell line as new model for drug screening and basic research
[J]. China Oncology, 2024, 34(6): 561-570.
|
[2] |
CHEN Hong, CAO Zhiyun.
Recent progress in the construction and application of patient-derived pancreatic cancer organoid models
[J]. China Oncology, 2024, 34(6): 590-597.
|
[3] |
ZHANG Qi, XIU Bingqiu, WU Jiong.
Progress of important clinical research of breast cancer in China in 2023
[J]. China Oncology, 2024, 34(2): 135-142.
|
[4] |
WANG Zhaobu, LI Xing, YU Xinmiao, JIN Feng.
Important research progress in clinical practice for early breast cancer in 2023
[J]. China Oncology, 2024, 34(2): 151-160.
|
[5] |
TAN Xiaolang, YAO Sha, WANG Guihua, PENG Luogen.
Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling
[J]. China Oncology, 2024, 34(10): 944-956.
|
[6] |
LI Tianjiao, YE Longyun, JIN Kaizhou, WU Weiding, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2023
[J]. China Oncology, 2024, 34(1): 1-12.
|
[7] |
QU Ning, WANG Yuting, MA Ben, WANG Yu.
Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022
[J]. China Oncology, 2023, 33(5): 423-430.
|
[8] |
JIANG Jinling, ZHOU Chenfei, WANG Chao, ZHAO Liqin, WU Junwei, ZHANG Jun.
Advanced progress in research and diagnosis of gastric cancer in 2022
[J]. China Oncology, 2023, 33(4): 303-314.
|
[9] |
ZHAO Haichao, GAO Qiang.
Progress in research, diagnosis, and treatment of hepatocellular carcinoma in 2022
[J]. China Oncology, 2023, 33(4): 315-326.
|
[10] |
TIAN Xi, XU Wenhao, ZHU Shuxuan, AIHETAIMUJIANG•Anwaier, SU Jiaqi, YE Shiqi, QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei.
Advances in the research, diagnosis and treatment of renal cell carcinoma in 2022
[J]. China Oncology, 2023, 33(3): 191-200.
|
[11] |
ZHENG Shengfeng, ZHU Yiping, YE Dingwei.
Advances in basic research, clinical diagnosis and treatment of bladder cancer in 2022
[J]. China Oncology, 2023, 33(3): 201-209.
|
[12] |
PAN Jian, ZHU Yao, DAI Bo, YE Dingwei.
Advances in basic research, clinical diagnosis and treatment of prostate cancer in 2022
[J]. China Oncology, 2023, 33(3): 210-217.
|
[13] |
ZENG Cheng, ZHANG Jian.
Leading research progress and prospect of antibody-drug conjugate in pancreatic cancer in 2022
[J]. China Oncology, 2023, 33(3): 235-240.
|
[14] |
FU Qingsheng, JIN Lei, ZHANG Xudong, XU Yingchen, ZHU Chunfu, QIN Xihu, WU Baoqiang.
Effect of tRF-Pro-CGG on the biological behavior of mouse pancreatic cancer cells and its molecular mechanism
[J]. China Oncology, 2023, 33(3): 241-249.
|
[15] |
YUE Ming, WANG Liwei, CUI Jiujie.
Research progress on the mechanism of organ-specific lung metastasis in pancreatic cancer
[J]. China Oncology, 2023, 33(11): 1026-1031.
|